Novavax Inc. closed 60.47% below its 52-week high of $17.81, which the company achieved on July 26th.

Novavax (NVAX) closed the most recent trading day at $6.61, moving -2.79% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.79% for the day. At the ...

The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.

The U.S. Centers for Disease Control and Prevention has ended its emergency response to the H5N1 bird flu outbreak, a move ...

The stock's fall snapped a three-day winning streak.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

For many, Novavax is #1 – the one and only COVID vaccine they would consider. This enthusiasm for Novavax isn’t new. As far back as 2022, news reports described a kind of Novavax fan club ...

Novavax's COVID-19 vaccine has been approved for use in Canadian adults, some 18 months after the federal government had announced a deal to produce the doses in Montreal. Content.

A limited supply of the updated Novavax vaccine is rolling out in Alberta this week with appointment booking starting Wednesday and shots going into arms as of Friday. Alberta Health said it has ...

Novavax is a small firm relative to other vaccine producers such as AstraZeneca and Pfizer. In 2019, before being chosen to participate in the U.S. Operation Warp Speed vaccine program, ...